Study of Ta-NPs plus radiation for recurrent retroperitoneal sarcoma
Treatments studied
Part of Cancer clinical trials.
This trial tests a new treatment that combines an investigational drug (Ta-NPs) with radiation therapy for people whose retroperitoneal sarcoma has come back after standard treatment. The goal is to see if this combination can help control the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of sarcoma called dedifferentiated liposarcoma or leiomyosarcoma that has returned after previous treatment.
- You have at least one tumor that can be injected with the study drug and treated with radiation.
- You are in generally good health, with adequate organ function and ability to perform daily activities.
- You have not had radiation to the tumor area in the last 6 months.
- You are not pregnant or breastfeeding and agree to use contraception during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of giving radiation called proton spatially fractionated radiotherapy (P-SFRT) combined with standard radiation for people with a type of sarcoma in the back of the belly. The goal is to see if this combination can treat the tumor more effectively.
This study looks at how well standard treatments work for people whose liposarcoma has come back in the same area. It helps doctors understand best ways to manage this rare cancer.
This trial tests a new approach for people with a rare type of cancer called retroperitoneal sarcoma, which grows in the back of the belly. It combines a short course of radiation and an immunotherapy drug before surgery, aiming to shrink the tumor and improve the chances of successful removal.
This study tests whether a short course of radiation before surgery can treat retroperitoneal sarcoma (a rare cancer in the back of the belly). It is for people whose tumor is removable and who have not had previous radiation in the same area.
This trial tests giving chemotherapy together with a targeted treatment before surgery for people with a high-risk retroperitoneal sarcoma. The goal is to shrink or control the tumor so surgery can potentially remove it with minimal remaining disease (R0/R1).
This trial is testing a new type of radiation therapy for advanced soft tissue sarcoma that has not responded to other treatments. The goal is to see if this therapy can shrink tumors and help control the cancer.
Hear when a new Locally Recurrent Retroperitoneal Soft Tissue Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.